Published 27 days ago

Why Is Vincerx Pharma (VINC) Stock Down 64% Today?

Summary by InvestorPlace

Vincerx Pharma stock is falling hard on Tuesday after the company failed to impress VINC shareholders with its latest clinical trial update.

0 Articles

All

Left

Center

Right

Vincerx Pharma stock is falling hard on Tuesday after the company failed to impress VINC shareholders with its latest clinical trial update.

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.

Total News Sources0

Leaning Left0Leaning Right0Center0Last Updated27 days agoBias Distribution

No sources with tracked biases.

Factuality

To view factuality data please Upgrade to Premium

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)